Table I.
Characteristics | RSV cases (2020-2021), n = 90 | RSV cases (2018-2019), n = 90 | P value |
---|---|---|---|
Median age in months (IQR) | 9.5 (1-28) | 8.5 (4-24) | .61∗ |
Age categories | .03 | ||
≤12 months | 49 (54.4%) | 58 (64.4%) | |
13-24 months | 17 (18.9%) | 14 (15.6%) | |
25-35 months | 8 (8.9%) | 1 (1.1%) | |
3-6 years | 11 (12.2%) | 13 (14.4%) | |
7-11 years | 5 (5.6%) | 1 (1.1%) | |
12-17 years | 0 (0%) | 3 (3.3%) | |
Reported sick contacts | 40 (44.4%) | 34 (37.8%) | .36 |
Comorbid conditions | |||
Prematurity | 7 (7.8%) | 13 (14.4%) | .16 |
Asthma/reactive airway disease | 4 (4.4%) | 13 (14.4%) | .02 |
Congenital cardiac disease | 4 (4.4%) | 3 (3.3%) | .63 |
Clinical syndromes | |||
Bronchiolitis | 61 (67.8%) | 52 (57.8%) | .58 |
Croup | 5 (5.6%) | 0 (0.0%) | .019 |
Asthma exacerbation | 0 (0%) | 9 (10.0%) | .02 |
Hospital admission | 59 (65.6%) | 42 (46.7%) | .01 |
Hypoxemia/oxygen requirement | 44 (48.9%) | 25 (27.8%) | .04 |
Values are number (%).
Wilcoxon signed-rank test.